相似文献
1
Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies.
Curr Probl Surg. 2022 Jan;59(1):101030. doi: 10.1016/j.cpsurg.2021.101030. Epub 2021 Jul 7.
2
Melanoma.
J Contin Educ Nurs. 2005 Nov-Dec;36(6):242-3. doi: 10.3928/0022-0124-20051101-02.
3
Cutaneous Melanoma-A Review in Detection, Staging, and Management.
Hematol Oncol Clin North Am. 2019 Feb;33(1):25-38. doi: 10.1016/j.hoc.2018.09.005.
4
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2012 Oct;23 Suppl 7:vii86-91. doi: 10.1093/annonc/mds229.
5
[Genetic diversity and immunological characteristics of malignant melanoma: the therapeutic spectrum].
Orv Hetil. 2015 Apr;156(15):583-91. doi: 10.1556/OH.2015.30122.
6
The role of targeted therapy for melanoma in the immunotherapy era.
Semin Cutan Med Surg. 2018 Jun;37(2):112-119. doi: 10.12788/j.sder.2018.021.
7
[Item 149--Epithelial and melanotic skin tumors: melanomas].
Ann Dermatol Venereol. 2012 Oct;139(11 Suppl):A150-7. doi: 10.1016/j.annder.2012.06.013. Epub 2012 Jul 25.
8
Indications and options for systemic therapy in melanoma.
Surg Clin North Am. 2014 Oct;94(5):1049-58, viii. doi: 10.1016/j.suc.2014.07.007. Epub 2014 Aug 6.
9
Mutation Testing and Adjuvant Systemic Therapy in Cutaneous Melanoma.
J Natl Compr Canc Netw. 2019 May 1;17(5.5):615-617. doi: 10.6004/jnccn.2019.5019.
10
Your patient with melanoma: staging, prognosis, and treatment.
Oncology (Williston Park). 2009 Jul;23(8 Suppl):13-21.
引用本文的文献
1
Primary Malignant Melanoma of the Oropharynx: A Rare Case of a Tonsillar Melanotic Lesion.
Cureus. 2025 Apr 20;17(4):e82637. doi: 10.7759/cureus.82637. eCollection 2025 Apr.
2
Lasalocid inhibits melanoma by down-regulating FOXM1 through PI3K/AKT and JNK/P38 MAPK pathways.
J Cancer. 2025 Jan 1;16(3):765-783. doi: 10.7150/jca.101798. eCollection 2025.
3
Advancements in Melanoma Therapies: From Surgery to Immunotherapy.
Curr Treat Options Oncol. 2024 Aug;25(8):1073-1088. doi: 10.1007/s11864-024-01239-8. Epub 2024 Jul 27.
4
De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression.
Cancer Res Commun. 2024 May 2;4(5):1174-1188. doi: 10.1158/2767-9764.CRC-23-0450.
5
Exercise sensitizes PD-1/PD-L1 immunotherapy as a hypoxia modulator in the tumor microenvironment of melanoma.
Front Immunol. 2023 Oct 9;14:1265914. doi: 10.3389/fimmu.2023.1265914. eCollection 2023.
6
Melatonin as a Repurposed Drug for Melanoma Treatment.
Med Sci (Basel). 2023 Jan 14;11(1):9. doi: 10.3390/medsci11010009.
7
F-FDG positron emission tomography-computed tomography has a low positive predictive value for detecting occult recurrence in asymptomatic patients with high-risk Stages IIB, IIC, and IIIA melanoma.
J Surg Oncol. 2022 Mar;125(3):525-534. doi: 10.1002/jso.26737. Epub 2021 Nov 6.
本文引用的文献
1
Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).
Nat Med. 2021 Feb;27(2):301-309. doi: 10.1038/s41591-020-01188-3. Epub 2021 Feb 8.
2
Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Patients With Melanoma of the Trunk and Extremities.
JAMA Dermatol. 2021 Jan 1;157(1):84-89. doi: 10.1001/jamadermatol.2020.3950.
3
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
N Engl J Med. 2020 Sep 17;383(12):1139-1148. doi: 10.1056/NEJMoa2005493. Epub 2020 Sep 2.
4
Current State of Target Treatment in BRAF Mutated Melanoma.
Front Mol Biosci. 2020 Jul 14;7:154. doi: 10.3389/fmolb.2020.00154. eCollection 2020.
5
Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma: A Systematic Review and Meta-analysis.
JAMA Dermatol. 2020 Sep 1;156(9):953-962. doi: 10.1001/jamadermatol.2020.1731.
6
The Current State of Mohs Surgery for the Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons.
Dermatol Surg. 2020 Oct;46(10):1267-1271. doi: 10.1097/DSS.0000000000002645.
7
Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.
JAMA Dermatol. 2020 Sep 1;156(9):1004-1011. doi: 10.1001/jamadermatol.2020.1729.
8
Vaccination with dendritic cells pulsed ex vivo with gp100 peptide-decorated liposomes enhances the efficacy of anti PD-1 therapy in a mouse model of melanoma.
Vaccine. 2020 Jul 31;38(35):5665-5677. doi: 10.1016/j.vaccine.2020.06.055. Epub 2020 Jul 9.
9
Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study.
J Natl Cancer Inst. 2021 Mar 1;113(3):318-328. doi: 10.1093/jnci/djaa088.
10
Real-world outcomes of advanced melanoma patients not represented in phase III trials.
Int J Cancer. 2020 Dec 15;147(12):3461-3470. doi: 10.1002/ijc.33162. Epub 2020 Jul 4.
Zotero 插件